Thyroid MIBG uptake in Parkinson’s disease with diabetes mellitus

被引：0
作者：
Wooyoung Jang
Joong-Seok Kim
Jin Whan Cho
Jin Young Ahn
Yun Young Choi
Hee-Tae Kim
机构：
[1] Hanyang University,Department of Neurology, College of Medicine
[2] Catholic University College of Medicine,Department of Neurology
[3] Samsung Medical Center,Department of Neurology
[4] Seoul Medical Center,Department of Neurology
[5] Hanyang University College of Medicine,Department of Nuclear Medicine
[6] University of Ulsan,Department of Neurology, Gangneung Asan Hospital
[7] College of Medicine,undefined
来源：
Clinical Autonomic Research | 2013年 / 23卷
关键词：
Parkinson’s disease; Nuclear medicine; Autonomic; Diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In our work, we investigated thyroid and cardiac MIBG uptake as potential differential markers. We observed reduced cardiac uptake of MIBG in PD and diabetic CAN, in agreement with the previous studies. However, there was a significant difference between the PD and diabetic cardiac autonomic neuropathy groups with respect to early and delayed thyroid MIBG uptake, in that reduced thyroid MIBG uptake was seen in PD but not in diabetic autonomic neuropathy. We therefore propose that this parameter could be a marker for identifying parkinsonism when it presents together with DM.
引用
收藏
页码：221 / 224
页数：3
相关论文
共 55 条
[1]  
Rascol O(2009)123I-metaiodobenzylguanidine scintigraphy in Parkinson’s disease and related disorders Mov Disord 24 S732-S741
[2]  
Schelosky L(1995)A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure J Auton Nerv Syst 25 230-234
[3]  
Hirayama MHS(2004)Cardiac autonomic neuropathy in the diabetic patient: does 123I-MIBG imaging have a role to play in early diagnosis? J Nucl Med Technol 32 66-71
[4]  
Koike Y(2005)Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson’s disease and multiple system atrophy Auton Neurosci 119 56-60
[5]  
Ito K(2005)Metaiodobenzylguanidine (MIBG) uptake in Parkinson’s disease also decreases at thyroid Ann Nucl Med 19 225-229
[6]  
Kato T(2000)Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific Eur J Nucl Med Mol Imaging 27 566-573
[7]  
Ikeda M(2001)Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes Mov Disord 16 217-225
[8]  
Hasegawa Y(2010)Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I metaiodobenzylguanidine myocardial scintigraphy and heart rate variability Eur J Nucl Med 37 1698-1705
[9]  
Takahashi A(2002)Orthostatic hypotension from sympathetic denervation in Parkinson’s disease Neurology 58 1247-1255
[10]  
Scott LA(2011)Thyroid disorders and diabetes mellitus J Thyroid Res 2011 439463-undefined
123456